West Pharmaceutical Services (WST) Cash from Operations (2009 - 2026)

West Pharmaceutical Services has disclosed Cash from Operations across 18 years of filings, most recently posting 89900000.0 for Q1 2026.

• Cash from Operations for Q1 2026 came in at 89900000.0, down 30.53% year-over-year; the trailing twelve-month figure through Mar 2026 was 715300000.0 (up 7.63% YoY), and the FY2025 annual result was 754800000.0, up 15.52% from the prior year.
• Cash from Operations came in at 89900000.0 for Q1 2026 at West Pharmaceutical Services, down from 251100000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 251100000.0 in Q4 2025 to a low of 89900000.0 in Q1 2026.
• The 5-year median for Cash from Operations is 173100000.0 (2022), against an average of 176388235.29.
• Across the five-year window, Cash from Operations soared 70.46% in 2022 and tumbled 30.53% in 2026, its largest moves.
• West Pharmaceutical Services' Cash from Operations stood at 230800000.0 in 2022, then gained by 3.6% to 239100000.0 in 2023, then declined by 20.49% to 190100000.0 in 2024, then soared by 32.09% to 251100000.0 in 2025, then tumbled by 64.2% to 89900000.0 in 2026.
• The last three Cash from Operations figures came in at 89900000.0 (Q1 2026), 251100000.0 (Q4 2025), and 197200000.0 (Q3 2025), per Business Quant data.